Get started
Author

Rezvan Rezaeinasab

Observed name: Rezaeinasab, Rezvan
ORCID: 0000-0002-5638-3106
Observed ORCID: 0000-0002-5638-3106
OpenAlex ID: A5000249173
Quinazolinone-based hybrids with diverse biological activities: A mini-review
2022 · Rezvan Rezaeinasab, Elham Jafari, et al. · Journal of Research in Medical Sciences · 28
Synthesis, Antimicrobial Activity and Molecular Docking Study of Novel N,2-Diphenylquinazolin-4-amine Derivatives: Synthesis, Docking and Antimicrobial Activities of Some Quinazoline Derivatives
2023 · Seydbagian, Nasser, Dehghan-Ghahfarokhi, Esmaeil, et al. · Iranian journal of pharmaceutical sciences · 1
PDF
One-pot Synthesis, Cytotoxic Evaluation and Molecular Docking of 3,4,7,8-tetrahydroquinazoline-2,5-(1H,6H)-dione Derivatives: Synthesis, cytotoxic evaluation and molecular docking of tetrahydroquinazolinones
2022 · Rafian-boroujeni, Mahdi, Rezaeinasab, Rezvan, et al. · International Pharmacy Acta · 1
PDF
Untitled
2022 · Keikhosravi, Navid, Dehghan-Ghahfarokhi, Esmaeil, et al. · Journal of Medicinal and Chemical Sciences · 1
PDF
Functionalized nanomagnetic graphene by ion liquid containing phosphomolybdic acid for facile and fast synthesis of paracetamol and aspirin
2021 · Elahe Nasiri, Feridoon Kooshki, et al. · Applied Organometallic Chemistry · 1
Molecular docking, synthesis, and cytotoxic evaluation of novel quinazoline-quinazolinone hybrid compounds
2026 · Majid Azarmi, Saman Rahimi, et al. · Research in Pharmaceutical Sciences
Molecular Docking of Some Quinazolinone Analogues as an EGFR Inhibitors
2021 · Rafieyanbroujeni, Mahdi, Rezaeinasab, Rezvan · یافته
PDF
Works count: 7
Citation count: 32
H-index: 1
I10-index: 1
Year
Topic
Type